Oral Mucormycosis in an Allogeneic Stem Cell Transplant Recipient
- *Corresponding Author:
- Ruiz Beguerie J
Austral University Hospital, Austral University
Av.Juan Domingo Perón 1500
Buenos Aires Province 1629
E-mail: [email protected]
Received date: Jun 13, 2016; Accepted date: Jul 30, 2016; Published date: Aug 3, 2016
Citation: Marchese ML, Ruiz Beguerie J, Fernandez A, Anaya J, Valdez R(2016) Oral Mucormycosis in an Allogeneic Stem Cell Transplant Recipient . J Dermatitis 1:105. doi: 10.4172/jod.1000105
Copyright: © 2016 Marchese ML, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Oral mucormycosis is an unusual and a lethal infection in patients following hematopoietic stem cell transplantation. A 20 year old man was diagnosed at the Austral University Hospital with palatal mucormycosis on day +20 after a hematopoietic stem cell transplant because of an acute leukemia lymphoblastic. There are less than 25 palatal mucormycosis cases reported in the literature. This case highlights the importance of being aware of this uncommon, but potentially fatal condition when assessing patients with transplants for a prompt diagnosis and intervention.